Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment

被引:74
作者
Aleksunes, Lauren M. [1 ]
Augustine, Lisa M. [2 ]
Scheffer, George L. [3 ]
Cherrington, Nathan J. [2 ]
Manautou, Jose E. [1 ]
机构
[1] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA
[2] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
[3] VU Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands
基金
美国国家卫生研究院;
关键词
transporters; cisplatin; kidney; toxicity;
D O I
10.1016/j.tox.2008.06.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The goal of this study was to identify alterations in mRNA and protein expression of various xenobiotic transport proteins in mouse kidney during cisplatin-induced acute renal failure. For this purpose, male C57BL/6J mice received a single dose of cisplatin (18 mg/kg, i.p.) or vehicle. Four days later, tissues were collected for assessment of plasma BUN, histo pathological analysis of renal lesions, and mRNA and Western blot analysis of renal transporters including organic anion and cation transporters (Oat, Oct), organic anion transporting polypeptides (Oatp), multidrug resistance-associated proteins (Mrp), multidrug resistance proteins (Mdr), breast cancer resistance protein (Bcrp) and multidrug and toxin extrusion proteins (Mate). Cisplatin treatment caused necrosis of renal proximal tubules along with elevated plasma BUN and renal kidney injury molecule-1 mRNA expression. Cisplatin-induced renal injury increased mRNA and protein levels of the efflux transporters Mrp2, Mrp4, Mrp5, Mdr1a and Mdr1b. Uptake transporters Oatp2al and Oatp2b1 mRNA were also up-regulated following cisplatin. By contrast, expression of Oat1, Oat2, Oct2 and Oatp1a1 mRNA was reduced in cisplatin-treated mice. Expression of several uptake and efflux transporters was unchanged in cisplatin-treated mice. Apical staining of Mrp2 and Mrp4 proteins was enhanced in proximal tubules from cisplatin-treated mice. Collectively, these expression patterns suggest Coordinated regulation of uptake and efflux pathways during cisplatin-induced renal injury. Reduced expression of basolateral and apical uptake transporters along with enhanced transcription of export transporters likely represents an adaptation to lower intracellular accumulation of chemicals, prevent their reabsorption and enhance urinary clearance. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 33 条
  • [1] Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride
    Aleksunes, LM
    Slitt, AM
    Cherrington, NJ
    Thibodeau, MS
    Klaassen, CD
    Manautou, JE
    [J]. TOXICOLOGICAL SCIENCES, 2005, 83 (01) : 44 - 52
  • [2] Tissue distribution and ontogeny of organic cation transporters in mice
    Alnouti, Y
    Petrick, JS
    Klaassen, CD
    [J]. DRUG METABOLISM AND DISPOSITION, 2006, 34 (03) : 477 - 482
  • [3] Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids
    Bao, Y
    Pucci, ML
    Chan, BS
    Lu, R
    Ito, S
    Schuster, VL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 282 (06) : F1103 - F1110
  • [4] Rat and mouse differences in gender-predominant expression of organic anion transporter (OAT1-3; SLC22A6-8) mRNA levels
    Buist, SCN
    Klaassen, CD
    [J]. DRUG METABOLISM AND DISPOSITION, 2004, 32 (06) : 620 - 625
  • [5] Chen ZS, 2002, CANCER RES, V62, P3144
  • [6] Transport of cyclic nucleotides and estradiol 17-β-D-glueuronide by multidrug resistance protein 4 -: Resistance to 6-mercaptopurine and 6-thioguanine
    Chen, ZS
    Lee, K
    Kruh, GD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (36) : 33747 - 33754
  • [7] Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps)
    Cheng, XG
    Maher, J
    Chen, C
    Klaassen, CD
    [J]. DRUG METABOLISM AND DISPOSITION, 2005, 33 (07) : 1062 - 1073
  • [8] Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2
    Ciarimboli, G
    Ludwig, T
    Lang, DF
    Pavenstädt, H
    Koepsell, H
    Piechota, HJ
    Haier, J
    Jaehde, U
    Zisowsky, J
    Schlatter, E
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (06) : 1477 - 1484
  • [9] Cui YH, 1999, MOL PHARMACOL, V55, P929
  • [10] Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter
    Demeule, M
    Brossard, M
    Béliveau, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1999, 277 (06) : F832 - F840